Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

IDEXX LABORATORIES INC /DE

In Vitro & In Vivo Diagnostic Substances | SIC: 2835
Phone: 2075560300

CIK: 0000874716
EIN: 010393723
State Location: ME
State of Inc.: DE

Nasdaq:IDXX

Form: 144

Filing Date: 20 May 2026
Report Date:
Accepted: 20 May 2026 04:30 p.m.
Accession Number: 0001958244-26-000299

Act: 33
File Number: 000-19271
Film Number: 261005414

Documents

Primary Document

Accepted: 20 May 2026 04:30 p.m.

0001958244-26-000299-index-headers.html

Last Modified: 20 May 2026 04:30 p.m.

0001958244-26-000299-index.html

Last Modified: 20 May 2026 04:30 p.m.

0001958244-26-000299.txt

Last Modified: 20 May 2026 04:30 p.m.

primary_doc.xml

Last Modified: 20 May 2026 04:30 p.m.